| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,496 |
6,205 |
$528K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,675 |
2,674 |
$281K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,207 |
3,891 |
$199K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
678 |
677 |
$79K |
| 93000 |
|
3,537 |
3,530 |
$73K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,453 |
3,378 |
$66K |
| 99441 |
|
1,253 |
1,173 |
$54K |
| 90677 |
|
194 |
194 |
$50K |
| 90686 |
|
1,653 |
1,652 |
$34K |
| 91320 |
|
237 |
237 |
$31K |
| 90688 |
|
804 |
804 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
246 |
244 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
317 |
311 |
$10K |
| 90480 |
|
236 |
236 |
$9K |
| 90750 |
|
83 |
83 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
4,317 |
4,204 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
244 |
228 |
$6K |
| 90656 |
|
264 |
264 |
$6K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,635 |
3,601 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
243 |
146 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
28 |
$3K |
| 90732 |
|
14 |
14 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
80 |
80 |
$1K |
| 90715 |
|
18 |
18 |
$724.41 |
| 90756 |
|
26 |
26 |
$656.78 |
| G0008 |
Administration of influenza virus vaccine |
17 |
17 |
$385.42 |
| 3079F |
|
275 |
270 |
$370.00 |
| 3074F |
|
306 |
301 |
$320.00 |
| 3075F |
|
118 |
115 |
$207.50 |
| 3078F |
|
173 |
170 |
$145.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$134.20 |
| 3725F |
|
3,122 |
3,027 |
$21.26 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
207 |
206 |
$0.00 |
| 1032F |
|
15 |
14 |
$0.00 |
| 99072 |
|
18 |
17 |
$0.00 |
| G9276 |
Documentation that patient is a current tobacco user |
14 |
13 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
1,986 |
1,970 |
$0.00 |
| 1036F |
|
2,007 |
1,991 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
339 |
336 |
$0.00 |
| 1000F |
|
2,242 |
2,223 |
$0.00 |
| 3008F |
|
1,311 |
1,308 |
$0.00 |
| 3048F |
|
15 |
15 |
$0.00 |
| 3061F |
|
15 |
15 |
$0.00 |
| 99000 |
|
13 |
12 |
$0.00 |